Getinge (GETI B.ST) Akcija Цена
Getinge Цена
Prihod je rastao 5,3 % godišnje u poslednjih 19 godina na 34,97 Млрд SEK. Zarada po akciji rasla je 3,1 % godišnje u poslednjih 19 godina. neto marža kompanije Getinge sada iznosi 6,5 %, pala sa 11,0 % pre nekoliko godina. Getinge trenutno nudi dividendni prinos od oko 1,72 %. Odnos isplate je oko 55 % dobiti. Dividenda je rasla 4,7 % godišnje u poslednjih 19 godina. Medijana analitičke ciljane cene je 231,03 SEK, odnosno ispod trenutnu cenu za 13,8 %. Od 14 analitičara 8 preporučuje kupovinu — ukupni konsenzus je Kupi.
Cena akcije Getinge
Pristupite ovim podacima preko Eulerpool API-ja
100.000 zahteva/mes. besplatno · bez kartice
Getinge poslovni model i analiza akcije
Često postavljana pitanja o akciji Getinge
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analitičari trenutno postavljaju prosečnu ciljanu cenu 238,81 SEK za akciju Getinge (medijana: 231,03 SEK), što znači -10,8 % u odnosu na poslednju cenu. Konsenzus se zasniva na 14 ocena.
14 analitičara trenutno ocenjuje akciju Getinge: 8 preporučuje kupovinu, 5 držanje i 1 prodaju. Za 2026 analitičari očekuju da Getinge ostvari prihod 35,26 Млрд SEK i zaradu po akciji 12,89 SEK.
Po trenutnom kursu akcija Getinge kotira 24,08 EUR (268,00 SEK).
Akcija Getinge (GETI B.ST) kotira na 9 berze, uključujući: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
očekivana prihod od Getinge je 35,26 Млрд SEK. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.
očekivana dobit od Getinge je 3,51 Млрд SEK. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.
Odnos cene i zarade (KGV) za Getinge je trenutno 20,80. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Getinge.
Odnos cene i prihoda (KUV) za Getinge je trenutno 2,07. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Getinge.
Eulpool score kvaliteta za Getinge je 4/10.
ISIN za Getinge je SE0000202624. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.
WKN za Getinge je 889714. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.
Ticker za Getinge je GETI B.ST. Simbol tikera se koristi za trgovinu akcijama Getinge na berzanskom tržištu.
Getinge акција
Getinge Peer grupa
Getinge Тикер
Getinge FIGI
Sve ključne metrke i detaljne analize Getinge u dubinskoj analizi
Naša analiza akcija za akciju Getinge uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Getinge. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: